Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1995
11/08/1995EP0680990A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/08/1995EP0680974A1 Novel muramyldipeptide derivatives
11/08/1995EP0680973A1 Peptides, process to prepare them and their use
11/08/1995EP0680972A1 Trifluoromethylketone peptide derivatives, process for their preparation and pharmaceutical compositions comprising them
11/08/1995EP0680765A1 Vaccine for nontypable haemophilus influenzae strain
11/08/1995EP0680764A2 Stable preparation for the treatment of blood coagulation disorders, comprising an activated coagulation factor and lipid vesicles
11/08/1995EP0680763A2 Stable preparation for the treatment of blood coagulation disorders comprising an activated coagulation factor and lipid vesicles
11/08/1995EP0680749A2 Cosmetic composition comprising an antagonist of substance P
11/08/1995EP0680469A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
11/08/1995EP0680337A1 Methods and compositions for the direct concentrated delivery of passive immunity
11/08/1995EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
11/08/1995EP0680334A1 Morphogen treatment of gastrointestinal ulcers
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680332A1 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0563254B1 Use of il-4 to enhance immune response to immunogens in vaccines
11/08/1995EP0512109B1 Oral pharmaceutical composition containing cyclosporin and process for preparing same
11/08/1995EP0423240B1 Modulation of virus-host cell interactions using cyclic oligosaccharides
11/08/1995EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
11/08/1995EP0412149B1 Use of il-7 in providing medications for stimulation of platelet production
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/08/1995EP0306496B1 Method for reducing the toxicity of lps and method for detoxifying an lps-containing therapeutic liquid
11/08/1995CN1111455A Peptide inhibitors of mitogenesis and motorgenesis
11/08/1995CN1111159A Specificity gene transfering technology of applying endothelial tissue ligand and sequential gene regulating amboceptor
11/08/1995CN1111158A Products containing G-CSF and TNF binding protein
11/07/1995US5464943 Fibroblast growth factor
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464938 Isolated viral protein TNF antagonists
11/07/1995US5464937 Type II Interleukin-1 receptors
11/07/1995US5464936 Compositions for identification of papillomavirus replication inhibitors
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464933 Synthetic peptide inhibitors of HIV transmission
11/07/1995US5464825 Metabolism, transport, protection
11/07/1995US5464823 Mammalian antibiotic peptides
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464821 And intraocular hypertension
11/07/1995US5464820 Specific inhibitors of tissue kallikrein
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/07/1995US5464818 From clostridium
11/07/1995US5464817 Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
11/07/1995US5464816 Autoimmune disease treatment with nonapeptides
11/07/1995US5464815 Extending plasma half-life of selectin by coadministering with compound which inhibits binding of selectin to low affinity heparin-like site on surface of cells of organ perfused with blood; assaying sensitivity; pharmaceutical composition
11/07/1995US5464814 Polymerized, pyridoxylated hemoglobin
11/07/1995US5464778 Glycoprotein ligand for P-selectin and methods of use thereof
11/07/1995US5464774 DNA sequence
11/07/1995US5464757 Corticotropin releasing factor, genetic engineering
11/07/1995US5464756 Processes and compositions for the isolation of human relaxin
11/07/1995US5464751 Purified protein or fragment bindable with p185, translation product of neu oncogene; dimer or trimer of protein; screening for mammalian tumor with p185 on tumor cell surfaces by contacting cells with protein, detecting bound protein
11/07/1995US5464634 Red blood cell surrogate
11/07/1995US5464615 Use of transglutaminases as immunosuppressants
11/07/1995US5464614 Stabilized superoxide dismutase (SOD) composition
11/07/1995CA2148746A1 Stable preparation for the treatment of blood coagulation disorders
11/07/1995CA2148672A1 Stable preparation for the treatment of blood coagulation disorders comprising an active coagulation promoting substance
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/07/1995CA1337519C Antibiotic ge 2270
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/06/1995CA2148650A1 Peptides derived from trifluoromethylketones; process for preparing the same and pharmaceutical compositions containing them
11/05/1995CA2122851A1 A cardiotropic formulation
11/03/1995CA2143923A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/02/1995WO1995029259A1 Method and means for detecting and treating disorders in the blood coagulation cascade
11/02/1995WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995WO1995029252A1 Oral preparation for patients with chronic renal insufficiency and other protein metabolic diseases
11/02/1995WO1995029245A2 Btf2 complex proteins and uses thereof
11/02/1995WO1995029243A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029241A2 Ribozymes with product ejection by strand displacement
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029237A1 Cardiotrophin and uses therefor
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029232A1 Chondroitinase ii and its use with chondroitinase i to achieve complete vitreal disinsertion
11/02/1995WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029189A1 FACTOR Xa INHIBITORS
11/02/1995WO1995029188A1 Human sperm diagnostic
11/02/1995WO1995029185A1 Novel megakaryocytic protein tyrosine kinases
11/02/1995WO1995029180A1 Porphocyanine and cnc-expanded porphyrins
11/02/1995WO1995028962A1 Inhibition of myelin destruction by interfering with the interaction between mac-2 and myelin
11/02/1995WO1995028961A1 Remedy for rheumatoid arthritis
11/02/1995WO1995028958A1 Induction of cytotoxic t lymphocytes (ctl) using antigenic peptides and a suitable adjuvant
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028956A2 Antifibrillatory agent in myocardial reperfusion
11/02/1995WO1995028955A1 PEPTIDES BINDING TO THE α2-MACROGLOBULIN RECEPTOR/LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN
11/02/1995WO1995028954A1 Formulations for factor ix
11/02/1995WO1995028953A1 Hepatopathy remedy
11/02/1995WO1995028952A1 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof
11/02/1995WO1995028951A1 Formulations for il-11
11/02/1995WO1995028950A1 Administration of platelet-derived growth factor and bone seeking drugs for osteoporosis and bone regeneration
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995WO1995028948A1 Compositions comprising dna damaging agents and p53
11/02/1995WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
11/02/1995WO1995028946A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
11/02/1995WO1995028942A1 Antisense oligomers for inhibiting human papillomaviruses
11/02/1995WO1995028941A1 Composition and method for treatment of cmv infection
11/02/1995WO1995028926A1 Pde iv inhibitors for treating multiple sclerosis
11/02/1995WO1995028921A1 Ecadotril as a renal protective agent
11/02/1995WO1995028920A1 Acids and acid salts and their use in delivery systems
11/02/1995WO1995028915A1 Red blood cell surrogate
1 ... 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 ... 3163